Charles River Laboratories International, Inc. CRL
292.84
(1.60)
(0.54%)
as of 25 Sep
- Market cap
- $14.1B
- P/E
- 0.0×
Follow CRL
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Charles River Laboratories International, Inc. (CRL) Operating cash flow
Charles River Laboratories International, Inc.'s operating cash flow for fiscal 2025 was $737.6M, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $582.1M. Over the past ten years it has ranged from $306.8M (fiscal 2015) to $760.8M (fiscal 2021); the current reading is higher than 91% of that period. Operating cash flow has risen for 3 consecutive fiscal years. Charles River Laboratories International, Inc. ranks 14th of 52 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Annual
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $737.6M | 0.42% |
| FY2024 | $734.6M | 7.41% |
| FY2023 | $683.9M | 10.37% |
| FY2022 | $619.6M | (18.55%) |
| FY2021 | $760.8M | 39.19% |
| FY2020 | $546.6M | 13.65% |
| FY2019 | $480.9M | 9.02% |
| FY2018 | $441.1M | 38.69% |
| FY2017 | $318.1M | 0.37% |
| FY2016 | $316.9M | 3.28% |
Quarterly
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $179.7M | 337.53% |
| Mar 2026 | $41.1M | (72.15%) |
| Dec 2025 | $147.5M | (31.01%) |
| Sep 2025 | $213.8M | 4.51% |
| 42 more quarters | Free account |
Against its own ten years
Low $306.8M
High $760.8M
Ten-year median
$546.6M
Current reading's percentile
91
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $1.9B |
| LH Labcorp Holdings Inc. compare | $1.6B |
| ICLR ICON PLC compare | $1.1B |
| MEDP Medpace Holdings, Inc. compare | $752.7M |
| QGEN QIAGEN N.V. compare | $654.5M |
| RVTY Revvity Inc. compare | $627.6M |
| CRL Charles River Laboratories International, Inc. | $582.1M |
| TWST Twist Bioscience Corporation compare | −$53.1M |
| GH Guardant Health, Inc. compare | −$185.2M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on CRL
- Revenue
- Net income
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement